C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63
about
SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamilyHUB1, a novel Krüppel type zinc finger protein, represses the human T cell leukemia virus type I long terminal repeat-mediated expressionRole of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenanceHuman CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulationProtein kinase activity is associated with CD63 in melanoma cells.Tetraspanins in viral infections: a fundamental role in viral biology?Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infectionRole of CD151, A tetraspanin, in porcine reproductive and respiratory syndrome virus infection.Current concepts regarding the HTLV-1 receptor complex.Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification.The SRP9/14 subunit of the human signal recognition particle binds to a variety of Alu-like RNAs and with higher affinity than its mouse homolog.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping systemCD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus.Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycansIdentification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherinTransmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins).Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission.Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.Antibodies to CD9, a tetraspan transmembrane protein, inhibit canine distemper virus-induced cell-cell fusion but not virus-cell fusion.Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages.Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses.Tetraspanin protein KAI1 expression in retinoblastoma.Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells.
P2860
Q24310639-91AB1E25-49E3-42A9-890A-B029B9E45584Q24312994-77B5207A-8854-4BBB-A70A-3B74BB3FAD21Q24683519-58B8D168-311A-4F9D-A782-B179AACB1DBEQ24805311-AAE4E868-9D0A-4EBF-90AB-1F79E9EB1279Q25257192-45B34C98-0178-4E5F-86BF-5A4F43C11742Q27470936-DF06B942-178D-4FF4-BA33-8DF454E13297Q27478138-D76C143B-28C7-4D33-94A9-378E03B3ECEBQ33287926-72F74F53-38D3-4C69-AEB6-77E6F58226A1Q33350169-9B2A58DA-D5D1-4514-B347-95949E949011Q33785946-232062D6-6D32-4E99-B2FD-F9AC1D864D30Q33853769-A3DE5541-75F2-4FD5-9CFA-21033024581EQ34351520-7CBB9966-946B-40CD-8075-01C4DAE0350FQ34624428-E4DCAD09-735D-45A5-BAF1-321A3E1E3481Q34914039-0945E30B-7604-4FB9-AAF4-6F4F4B174976Q35000087-DEBA1ADC-90AD-4D9A-9AB0-18A7C8E0C469Q35753387-62686FF4-986F-4E5D-A6A2-2D3AE7DF8819Q35782407-21BEA7A0-73D5-450F-B9AA-D2C523681406Q35787114-A6F19B95-749D-4011-BF7C-37D85CFE1D79Q35871408-88CBD9F5-C541-4089-8838-19AD945E8E4CQ35874613-EB6CBCCD-EA2D-4B60-9E61-22D83946F050Q35876633-CE76FE12-8295-46E8-B3CD-561B77718512Q36464718-C303C5A1-A00A-4992-AF73-F108AF4C889DQ36620457-DEF35720-E66C-4421-BD75-8177468D0B96Q36927799-7D1C857D-0515-4BD1-96BD-1E090A43DE57Q37071920-70793D7E-CB4F-466F-9A2C-77C6B0D5CB3CQ37379538-7D0204CB-60A7-45A2-B27D-CB8E382747D7Q37410721-9FC38C06-51B3-43F2-A76D-D762A356EE9DQ39069264-422CE38D-CE78-459B-898B-BF19F955B1CFQ39592728-0376485A-BF0F-425A-9A74-E74049B2A1D3Q39732524-5AFAB0C7-0325-4102-9483-A7E225D6C594Q39877204-05AFFB13-8689-4475-A886-78C7F932CCC5Q43007975-E4A42CEA-ACF3-49FC-B21D-F852C032B713Q48003105-5F9B2B4B-2AB8-416A-A82F-B4D4186B46AE
P2860
C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@ast
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@en
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@nl
type
label
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@ast
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@en
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@nl
prefLabel
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@ast
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@en
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@nl
P2093
P921
P1476
C33 antigen recognized by mono ...... ding CD9, CD37, CD53, and CD63
@en
P2093
K Fukudome
M Nishimura
N Fukuhara
P304
P407
P577
1992-11-01T00:00:00Z